Skip to main content
UniHealth

Doctor search

Sankar Narayan Niranjan, MD

Nephrology · Stanford

NPI 1497752802

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
13
2 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

13 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Niranjan’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

13 of 13 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$18,499

Medicare paid this office $18,499 for 127 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)121$17,134$100

Who their Medicare patients are

127 Original Medicare patients in 2024. Average age 80 · 85 and older 32% · Women 50% · Also on Medicaid 27% · Health risk score 1.98. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 53% · Coronary heart disease 46% · Heart failure 39% · Atrial fibrillation 37% · Depression 24% · COPD 16% · Cancer 15% · Stroke 15% · Dementia 9%.

The office billed $46,205, Medicare allowed $24,593 and paid $18,499; for 186 services of 6 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024127186801.98$46,205$18,499
2023326996764.08$490,555$121,706
20223671,345754.00$692,945$168,649
20213881,570744.44$690,235$190,137
20203641,494734.99$652,518$162,952
20193941,847734.97$879,640$203,857
20184582,091744.98$912,017$219,661
20176142,531744.54$972,418$245,843
20165342,951734.94$1,019,739$234,751
20155715,483744.60$957,816$250,506
20146534,739754.36$1,123,951$263,871
20137024,295734.83$1,152,412$261,929

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Dialysis services, 4 or more physician visits per month (20 years or older)21$40,366$290
Return visit (30+ min)140$20,636$93
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes102$14,150$65
Hemodialysis procedure with physician evaluation54$6,949$57
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes33$4,916$98
Initial hospital care with moderate level of medical decision making at least 75 minutes35$4,872$135
New patient visit (45+ min)29$3,765$130
Dialysis procedure including 1 evaluation19$2,621$67
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes17$1,936$102
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$657$41
Manual urinalysis test with examination using microscope, non-automated12$47$4

2022: 13 services

Original Medicare services billed in 2022
Dialysis services, 4 or more physician visits per month (20 years or older)32$65,901$301
Return visit (30+ min)133$20,680$96
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes117$15,820$59
Hemodialysis procedure with physician evaluation74$10,746$61
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes48$7,142$84
Initial hospital care with moderate level of medical decision making at least 75 minutes48$7,112$148
Dialysis procedure including 1 evaluation24$5,596$72
Critical care, first 30-74 minutes29$5,525$173
New patient visit (45+ min)41$5,182$126
Dialysis services, 2-3 physician visits per month (20 years or older)15$5,004$250
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes22$2,701$113
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes12$418$32
Manual urinalysis test with examination using microscope, non-automated20$80$4

2021: 14 services

Original Medicare services billed in 2021
Dialysis services, 4 or more physician visits per month (20 years or older)39$69,235$305
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes156$20,909$60
Return visit (30+ min)107$18,460$101
Initial hospital care with moderate level of medical decision making at least 75 minutes84$14,588$166
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes65$11,142$86
Hemodialysis procedure with physician evaluation82$10,189$61
Dialysis services, 2-3 physician visits per month (20 years or older)16$6,094$254
Critical care, first 30-74 minutes28$5,738$185
Dialysis procedure including 1 evaluation25$4,709$74
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes25$3,439$115
New patient visit (45+ min)26$3,213$124
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes17$589$31
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within t18$152$7
Manual urinalysis test with examination using microscope, non-automated19$76$4

2020: 17 services

Original Medicare services billed in 2020
Dialysis services, 4 or more physician visits per month (20 years or older)34$48,706$244
Home dialysis services per month (20 years or older)15$21,374$206
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes134$17,782$61
Hemodialysis procedure with physician evaluation92$11,782$62
Return visit (30+ min)86$11,669$86
Initial hospital care with moderate level of medical decision making at least 75 minutes59$10,300$169
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes55$7,730$89
Dialysis procedure including 1 evaluation30$6,507$73
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes42$5,766$118
Critical care, first 30-74 minutes14$3,760$188
New patient visit (45+ min)27$3,728$138
Dialysis services, 2-3 physician visits per month (20 years or older)12$3,130$196
Telephone medical discussion with physician, 11-20 minutes32$2,281$63
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within t44$554$10
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic34$489$13
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$468$33
Manual urinalysis test with examination using microscope, non-automated17$68$4

2019: 13 services

Original Medicare services billed in 2019
Dialysis services, 4 or more physician visits per month (20 years or older)52$69,938$241
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes182$25,695$62
Home dialysis services per month (20 years or older)13$23,215$202
Return visit (30+ min)102$16,347$84
Hemodialysis procedure with physician evaluation86$13,686$62
Initial hospital care with moderate level of medical decision making at least 75 minutes69$12,350$167
Dialysis services, 2-3 physician visits per month (20 years or older)23$7,134$204
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes44$6,061$114
Dialysis procedure including 1 evaluation24$5,891$73
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes37$4,682$88
Critical care, first 30-74 minutes12$2,459$189
New patient visit (45+ min)16$1,928$120
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes15$507$32

2018: 13 services

Original Medicare services billed in 2018
Dialysis services, 4 or more physician visits per month (20 years or older)46$71,763$235
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes246$37,816$61
Home dialysis services per month (20 years or older)16$25,404$195
Initial hospital care with moderate level of medical decision making at least 75 minutes105$18,245$171
Return visit (30+ min)104$16,913$88
Hemodialysis procedure with physician evaluation109$14,078$61
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes49$6,397$112
Dialysis services, 2-3 physician visits per month (20 years or older)21$6,167$199
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$4,642$88
Dialysis procedure including 1 evaluation18$3,037$72
New patient visit (45+ min)14$1,828$131
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes44$1,623$33
Manual urinalysis test with examination using microscope, non-automated11$43$4

2017: 13 services

Original Medicare services billed in 2017
Dialysis services, 4 or more physician visits per month (20 years or older)60$63,484$239
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes331$47,522$61
Initial hospital care with moderate level of medical decision making at least 75 minutes120$21,812$169
Home dialysis services per month (20 years or older)17$20,873$199
Return visit (30+ min)111$17,954$86
Hemodialysis procedure with physician evaluation131$15,969$60
Dialysis services, 2-3 physician visits per month (20 years or older)29$10,644$201
Dialysis services, 4 or more physician visits per month (20 years or older)25$9,313$239
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes51$8,353$88
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes51$7,076$114
Dialysis procedure including 1 evaluation39$5,853$72
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes80$2,957$32
New patient visit (45+ min)22$2,863$130

2016: 16 services

Original Medicare services billed in 2016
Dialysis services, 4 or more physician visits per month (20 years or older)65$76,355$234
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes275$39,837$59
Home dialysis services per month (20 years or older)14$20,250$197
Hemodialysis procedure with physician evaluation129$17,618$59
Initial hospital care with moderate level of medical decision making at least 75 minutes96$17,167$167
Return visit (30+ min)108$16,747$83
Dialysis services, 2-3 physician visits per month (20 years or older)33$8,769$183
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes66$8,764$111
Injection, epoetin alfa, (for non-esrd use), 1000 units17$7,379None
Dialysis procedure including 1 evaluation40$7,034$71
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$3,845$85
New patient visit (45+ min)23$2,856$124
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes62$2,267$32
Short return visit14$785$33
Injection of drug or substance under skin or into muscle17$644$21
Blood count, hemoglobin11$51$3

2015: 14 services

Original Medicare services billed in 2015
Dialysis services, 4 or more physician visits per month (20 years or older)56$62,395$239
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes318$51,270$61
Injection, epoetin alfa, (for non-esrd use), 1000 units34$28,440None
Return visit (30+ min)105$19,007$88
Hemodialysis procedure with physician evaluation132$18,557$61
Initial hospital care with moderate level of medical decision making at least 75 minutes92$17,091$171
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes73$9,930$114
Dialysis services, 2-3 physician visits per month (20 years or older)28$9,271$202
Dialysis procedure including 1 evaluation34$5,860$72
Short return visit32$3,804$37
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes60$2,686$33
Injection of drug or substance under skin or into muscle34$2,630$22
New patient visit (45+ min)17$2,214$130
Blood count, hemoglobin30$288$3

2014: 15 services

Original Medicare services billed in 2014
Dialysis services, 4 or more physician visits per month (20 years or older)58$88,576$232
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes349$47,114$59
Initial hospital care with moderate level of medical decision making at least 75 minutes156$27,864$167
Hemodialysis procedure with physician evaluation171$22,502$60
Return visit (30+ min)112$21,574$84
Injection, epoetin alfa, (for non-esrd use), 1000 units41$19,432None
Dialysis services, 2-3 physician visits per month (20 years or older)27$6,435$201
Dialysis procedure including 1 evaluation31$5,087$71
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes25$3,002$111
Short return visit44$2,822$37
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes76$2,764$30
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$2,506$86
New patient visit (45+ min)17$2,032$120
Injection of drug or substance under skin or into muscle41$1,917$22
Blood count, hemoglobin45$273$3

2013: 15 services

Original Medicare services billed in 2013
Dialysis services, 4 or more physician visits per month (20 years or older)170$97,494$232
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes313$37,469$58
Initial hospital care with moderate level of medical decision making at least 75 minutes160$29,793$165
Hemodialysis procedure with physician evaluation150$21,391$59
Return visit (30+ min)105$19,955$84
Injection, epoetin alfa, (for non-esrd use), 1000 units31$15,540None
Home dialysis services per month (20 years or older)23$12,001$197
Dialysis services, 2-3 physician visits per month (20 years or older)26$5,973$199
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes142$5,406$32
Dialysis procedure including 1 evaluation37$4,391$69
New patient visit (45+ min)26$3,579$138
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes25$2,818$113
Short return visit30$1,834$37
Injection of drug or substance under skin or into muscle31$1,581$22
Blood count, hemoglobin33$212$3

Medicaid work

$1,379 in 2024

Medicaid paid $1,379 for 112 billed services this clinician did in 2024, up to 39 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Return visit (30+ min)112$1,379
Medicaid work by year
2024112139$1,379
2023690426$18,444
20221,3691126$75,543
2021967927$36,425
2020666425$35,653
2019980529$42,084
20181,378830$39,318
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month107$8,887
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional92$3,436
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES242$3,340
Return visit (30+ min)249$2,781

2022

Largest Medicaid services in 2022
UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT475$41,079
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month225$19,995
Injection, epoetin alfa, 100 units (for esrd on dialysis)117$4,507
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES261$4,435
Return visit (30+ min)133$2,578
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional56$2,554
Iron sucrose injection39$396
TOBACCO NON-USER12$0
Bmi documented outside normal parameters, no follow-up plan documented, no reason given13$0
Most recent diastolic blood pressure < 90 mmhg26$0
Bp scrn perf rec interval12$0

2021

Largest Medicaid services in 2021
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month272$22,906
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES352$6,139
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional156$5,041
Return visit (30+ min)112$1,828
1ST HOSP IP/OBS HIGH 7513$512
TOBACCO NON-USER16$0
Bmi documented outside normal parameters, no follow-up plan documented, no reason given17$0
Most recent diastolic blood pressure < 90 mmhg16$0
Bp scrn perf rec interval13$0

2020

Largest Medicaid services in 2020
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month257$26,898
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES270$4,858
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional97$3,083
Return visit (30+ min)42$815

2019

Largest Medicaid services in 2019
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month283$29,708
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES446$6,924
Return visit (30+ min)133$2,348
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional94$2,091
1ST HOSP IP/OBS HIGH 7524$1,013

2018

Largest Medicaid services in 2018
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month279$27,669
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional220$5,696
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES680$4,172
Return visit (30+ min)130$1,365
1ST HOSP IP/OBS HIGH 7512$416
TOBACCO NON-USER16$0
Bmi documented outside normal parameters, no follow-up plan documented, no reason given12$0
Most recent diastolic blood pressure < 90 mmhg29$0

Drugs they prescribed that Part D paid

$98,316

Pharmacies billed $98,316 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 639) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.

492 generic and fewer than 11 brand-name prescriptions · $98,316 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Farxiga78$60,941$781
Jardiance15$12,597$840
Clinolipid15$3,630$242
Calcitriol65$941$14
Torsemide36$831$23
See all 17 drugs
Every Part D drug this clinician prescribed
Farxiga78$60,941$781
Jardiance15$12,597$840
Clinolipid15$3,630$242
Calcitriol65$941$14
Torsemide36$831$23
Amlodipine Besylate104$526$5
Calcium Acetate15$495$33
Potassium Chloride15$354$24
Spironolactone40$230$6
Tamsulosin15$223$15
Furosemide31$180$6
Allopurinol13$162$12
Doxazosin Mesylate12$141$12
Losartan13$89$7
Lisinopril18$82$5
Atenolol12$29$2
Ramipril14$18$1

Year by year

Part D prescribing by year
20246391320% (0)None$98,316
20239151850% (0)26%$133,201
20228581710% (0)25%$209,420
20217841550% (0)22%$167,259
20207121260% (0)21%$118,764
2019850139None25%$156,505
20188491350% (0)None$179,515
20171,2401300% (0)45%$345,169
20161,1211210% (0)None$318,306
20151,2961272% (20)36%$320,551
20141,3221272% (28)33%$192,283
20131,4361712% (21)34%$232,080

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 18 drugs

Part D drugs prescribed in 2023
Farxiga68$48,932$720
Clinolipid61$16,902$277
Sevelamer Carbonate50$7,797$156
Prosol30$4,450$148
Januvia21$4,421$211
Calcium Acetate26$1,495$57
Calcitriol74$1,462$20
Torsemide51$1,403$28
Potassium Chloride23$1,132$49
Amlodipine Besylate112$754$7
Spironolactone41$417$10
Furosemide38$311$8
Tamsulosin14$282$20
Allopurinol15$204$14
Losartan12$149$12
Lisinopril23$127$6
Carvedilol17$87$5
Atenolol14$62$4

2022: 25 drugs

Part D drugs prescribed in 2022
Velphoro19$74,624$3,928
Sevelamer Carbonate35$12,641$361
Farxiga19$12,216$643
Prosol79$11,458$145
Clinolipid20$5,727$286
Calcium Acetate28$3,695$132
Edarbyclor11$2,523$229
Januvia12$2,220$185
Calcitriol46$1,541$34
Torsemide50$1,500$30
Diltiazem 24hr Er (Cd)13$1,008$78
Amlodipine Besylate96$724$8
Hydralazine15$651$43
Spironolactone35$431$12
Lisinopril28$322$11
Losartan14$314$22
Valsartan14$306$22
Furosemide21$263$13
Doxazosin Mesylate14$232$17
Tamsulosin11$172$16
Enalapril Maleate11$152$14
Allopurinol13$136$10
Carvedilol15$100$7
Ciprofloxacin13$49$4
Atenolol15$45$3

2021: 22 drugs

Part D drugs prescribed in 2021
Velphoro27$65,255$2,417
Auryxia12$27,932$2,328
Sevelamer Carbonate35$16,128$461
Prosol59$9,010$153
Calcium Acetate18$2,933$163
Edarbyclor13$2,895$223
Clinisol13$2,364$182
Calcitriol44$1,543$35
Torsemide38$885$23
Spironolactone63$748$12
Amlodipine Besylate93$747$8
Diltiazem 24hr Er (Cd)11$639$58
Hydralazine15$479$32
Losartan30$390$13
Doxazosin Mesylate13$344$26
Metoprolol13$287$22
Lisinopril16$207$13
Allopurinol11$182$17
Furosemide14$124$9
Tamsulosin14$92$7
Gabapentin16$88$6
Prednisone11$72$7

2020: 16 drugs

Part D drugs prescribed in 2020
Auryxia23$44,684$1,943
Sevelamer Carbonate30$14,644$488
Intralipid12$4,787$399
Prosol30$4,437$148
Calcium Acetate20$3,165$158
Edarbyclor13$2,815$217
Calcitriol49$1,334$27
Amlodipine Besylate108$1,011$9
Torsemide59$999$17
Losartan21$413$20
Spironolactone39$388$10
Doxazosin Mesylate12$333$28
Terazosin16$323$20
Furosemide14$92$7
Lisinopril16$87$5
Prednisone12$54$4

2019: 19 drugs

Part D drugs prescribed in 2019
Auryxia27$67,608$2,504
Intralipid44$13,383$304
Sevelamer Carbonate29$7,414$256
Prosol52$6,567$126
Calcium Acetate32$2,660$83
Calcitriol65$1,461$22
Torsemide57$1,126$20
Amlodipine Besylate104$1,025$10
Hydralazine17$944$56
Lidocaine-Prilocaine23$627$27
Midodrine14$556$40
Spironolactone37$415$11
Terazosin24$398$17
Doxazosin Mesylate11$273$25
Metoprolol19$271$14
Losartan13$242$19
Furosemide25$147$6
Atenolol21$122$6
Lisinopril13$101$8

2018: 20 drugs

Part D drugs prescribed in 2018
Renvela30$55,522$1,851
Auryxia23$37,661$1,637
Sevelamer Carbonate27$27,654$1,024
Intralipid52$13,443$259
Prosol20$3,583$179
Calcium Acetate33$2,935$89
Calcitriol70$1,712$24
Lidocaine-Prilocaine15$1,277$85
Paricalcitol20$1,257$63
Chlorthalidone22$970$44
Polyethylene Glycol 335013$903$69
Torsemide50$766$15
Doxazosin Mesylate27$561$21
Amlodipine Besylate81$500$6
Furosemide38$202$5
Metoprolol16$196$12
Terazosin18$186$10
Allopurinol16$138$9
Pantoprazole17$121$7
Carvedilol11$80$7

2017: 30 drugs

Part D drugs prescribed in 2017
Renvela67$95,642$1,427
Sensipar49$89,353$1,824
Prosol196$45,587$233
Auryxia19$23,825$1,254
Intralipid29$6,773$234
Calcium Acetate33$5,376$163
Eliquis13$5,150$396
Dextrose in Water55$2,488$45
Midodrine23$1,493$65
Lidocaine-Prilocaine31$1,441$46
Paricalcitol11$1,051$96
Chlorthalidone17$882$52
Valsartan23$803$35
Calcitriol30$626$21
Torsemide39$597$15
Doxazosin Mesylate20$494$25
Amlodipine Besylate74$431$6
Metoprolol20$425$21
Valsartan-Hydrochlorothiazide26$402$15
Losartan34$361$11
Diltiazem 24hr Er14$342$24
Furosemide51$184$4
Pantoprazole22$168$8
Carvedilol37$166$4
Omeprazole13$166$13
Lisinopril18$137$8
Allopurinol13$105$8
Trazodone11$88$8
Spironolactone13$83$6
Zolpidem14$47$3

2016: 26 drugs

Part D drugs prescribed in 2016
Renvela91$129,962$1,428
Sensipar71$97,671$1,376
Fosrenol12$37,664$3,139
Prosol92$16,733$182
Calcium Acetate79$11,015$139
Chlorthalidone29$1,390$48
Valsartan22$881$40
Calcitriol39$755$19
Torsemide44$674$15
Diltiazem 24hr Er15$504$34
Losartan34$328$10
Valsartan-Hydrochlorothiazide19$324$17
Amlodipine Besylate70$323$5
Potassium Chloride18$276$15
Omeprazole33$201$6
Carvedilol37$181$5
Spironolactone34$174$5
Doxazosin Mesylate15$171$11
Terazosin17$166$10
Lisinopril35$164$5
Atorvastatin15$156$10
Furosemide41$130$3
Allopurinol12$101$8
Pantoprazole21$92$4
Atenolol11$55$5
Lactulose13$34$3

2015: 38 drugs

Part D drugs prescribed in 2015
Renvela78$110,366$1,415
Sensipar94$101,744$1,082
Fosrenol28$54,345$1,941
Calcium Acetate73$13,312$182
Prosol49$7,711$157
Nexium12$2,975$248
Lyrica14$2,854$204
Diovan11$2,655$241
Clonidine13$2,615$201
Valsartan13$1,404$108
Labetalol12$1,226$102
Chlorthalidone21$1,011$48
Calcitriol48$758$16
Valsartan-Hydrochlorothiazide17$704$41
Torsemide33$557$17
Hydralazine23$422$18
Midodrine12$410$34
Doxazosin Mesylate23$389$17
Losartan36$382$11
Pravastatin14$375$27
Amlodipine Besylate87$364$4
Levothyroxine21$285$14
Insulin11$284$26
Furosemide63$278$4
Atorvastatin25$205$8
Carvedilol34$203$6
Spironolactone25$196$8
Omeprazole28$193$7
Lisinopril49$181$4
Potassium Chloride11$172$16
Metoprolol11$146$13
Gabapentin23$138$6
Tramadol18$107$6
Escitalopram16$97$6
Pantoprazole18$96$5
Lactulose12$68$6
Metoprolol13$60$5
Pramipexole Dihydrochloride12$54$5

2014: 39 drugs

Part D drugs prescribed in 2014
Sensipar57$47,789$838
Renvela42$37,365$890
Fosrenol15$31,496$2,100
Calcium Acetate68$14,039$206
Prosol72$11,497$160
Intralipid22$6,781$308
Diovan28$5,584$199
Clonidine13$2,570$198
Calcitriol61$1,514$25
Metoprolol32$711$22
Diltiazem 24hr Er12$646$54
Losartan51$585$11
Pravastatin13$465$36
Polyethylene Glycol 335015$462$31
Omeprazole26$449$17
Amlodipine Besylate86$443$5
Chlorthalidone12$420$35
Quinapril14$408$29
Torsemide30$388$13
Fenofibrate12$372$31
Doxazosin Mesylate15$340$23
Levothyroxine22$307$14
Spironolactone40$305$8
Carvedilol35$299$9
Furosemide46$280$6
Escitalopram17$248$15
Hydralazine19$235$12
Tramadol26$181$7
Pantoprazole21$160$8
Lovastatin14$160$11
Lisinopril31$150$5
Gabapentin15$131$9
Pramipexole Dihydrochloride12$122$10
Atorvastatin12$111$9
Metolazone13$110$8
Metoprolol20$99$5
Simvastatin21$97$5
Minoxidil11$91$8
Clonazepam11$84$8

2013: 43 drugs

Part D drugs prescribed in 2013
Renvela66$66,749$1,011
Sensipar62$59,099$953
Calcium Acetate87$18,751$216
Fosrenol18$17,994$1,000
Diovan32$5,557$174
Lantus25$3,829$153
Lantus Solostar11$2,819$256
Exforge11$1,980$180
Novolog12$1,828$152
Calcitriol37$1,387$37
Lidocaine-Prilocaine36$1,283$36
Diltiazem 24hr Er26$1,122$43
Labetalol14$1,054$75
Losartan54$850$16
Escitalopram18$722$40
Megestrol Acetate15$682$45
Amlodipine Besylate69$639$9
Metoprolol21$593$28
Torsemide26$563$22
Chlorthalidone24$526$22
Omeprazole30$512$17
Fenofibrate13$510$39
Diltiazem 24hr Cd11$423$38
Carvedilol43$407$9
Losartan-Hydrochlorothiazide19$395$21
Bd Ultra-Fine Pen Needle12$387$32
Doxazosin Mesylate32$364$11
Lisinopril38$341$9
Insulin12$327$27
Metolazone18$308$17
Potassium Chloride17$297$17
Spironolactone14$252$18
Hydralazine17$236$14
Furosemide39$236$6
Hydroxyzine12$226$19
Pramipexole Dihydrochloride13$206$16
Isosorbide Mononitrate Er14$188$13
Levothyroxine22$178$8
Metoprolol23$155$7
Tramadol20$146$7
Simvastatin12$71$6
Zolpidem14$69$5
Terazosin12$60$5

Money from drug and device companies

$122 in 2025

Industry payments by year
202512None$122
2024612None$444
20231011None$497
20221011None$337
202033None$106
2019818None$1,682

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Idorsia Pharmaceuticals USTryvio$122
2 payments
  • Meals for Tryvio · 2025-08-08 · $27
  • Meals for Tryvio · 2025-07-22 · $95
See all 2 published payments
Every published payment
Idorsia Pharmaceuticals USMeals · 2025-08-08Tryvio$27
Idorsia Pharmaceuticals USMeals · 2025-07-22Tryvio$95
See earlier years (2024, 2023, 2022, 2020, 2019)

2024: $444

Payments by company in 2024
AmgenAranesp$177
5 payments
  • Meals for Aranesp · 2024-08-28 · $7
  • Meals for Aranesp · 2024-08-08 · $30
  • Meals for Aranesp · 2024-05-16 · $59
  • Meals for Aranesp · 2024-05-16 · $59
  • Meals for Aranesp · 2024-03-23 · $23
Baxter HealthcareRenal - Chronic$149
2 payments
  • Meals · 2024-04-30 · $131
  • Meals for Renal - Chronic · 2024-04-15 · $18
Akebia TherapeuticsVafseo$49
2 payments
  • Meals for Vafseo · 2024-07-24 · $26
  • Meals for Auryxia · 2024-07-16 · $23
Novartis PharmaceuticalsNone$28
1 payment
  • Meals · 2024-08-22 · $28
Lilly USAJardiance$22
1 payment
  • Meals for Jardiance · 2024-07-24 · $22
Novo NordiskOzempic$20
1 payment
  • Meals for Ozempic · 2024-12-03 · $20

2023: $497

Payments by company in 2023
AmgenParsabiv$162
2 payments
  • Meals for Parsabiv · 2023-12-12 · $29
  • Meals · 2023-11-29 · $133
Baxter HealthcareNone$125
1 payment
  • Meals · 2023-03-16 · $125
AstraZeneca Pharmaceuticals LPNone$64
1 payment
  • Meals · 2023-02-08 · $64
GlaxoSmithKlineBenlysta$28
1 payment
  • Meals for Benlysta · 2023-01-31 · $28
Horizon Therapeutics plcKrystexxa$26
1 payment
  • Meals for Krystexxa · 2023-08-22 · $26
Otsuka America PharmaceuticalJynarque$21
1 payment
  • Meals for Jynarque · 2023-07-05 · $21
ArdelyxIbsrela$20
1 payment
  • Meals for Ibsrela · 2023-11-28 · $20
Travere TherapeuticsNone$19
1 payment
  • Meals · 2023-03-09 · $19
Calliditas Therapeutics USTarpeyo$18
1 payment
  • Meals for Tarpeyo · 2023-12-05 · $18
Vifor PharmaVeltassa$14
1 payment
  • Meals for Veltassa · 2023-03-21 · $14

2022: $337

Payments by company in 2022
Travere TherapeuticsNone$83
1 payment
  • Meals · 2022-11-01 · $83
Aurinia Pharma U.S.Lupkynis$75
1 payment
  • Meals for Lupkynis · 2022-10-19 · $75
Bayer HealthCare PharmaceuticalsKerendia$35
2 payments
  • Meals for Kerendia · 2022-06-10 · $19
  • Meals for Kerendia · 2022-04-01 · $17
Mallinckrodt Hospital ProductsTerlivaz$30
1 payment
  • Meals for Terlivaz · 2022-11-09 · $30
GlaxoSmithKlineBenlysta$29
1 payment
  • Meals for Benlysta · 2022-09-13 · $29
AstraZeneca Pharmaceuticals LPFarxiga$21
1 payment
  • Meals for Farxiga · 2022-05-12 · $21
Otsuka America PharmaceuticalJynarque$18
1 payment
  • Meals for Jynarque · 2022-05-31 · $18
Akebia TherapeuticsNone$17
1 payment
  • Meals · 2022-03-24 · $17
Vifor PharmaVeltassa$15
1 payment
  • Meals for Veltassa · 2022-08-02 · $15
Baxter HealthcareRenal - Pd$14
1 payment
  • Meals for Renal - Pd · 2022-07-12 · $14

2020: $106

Payments by company in 2020
Bard Peripheral VascularCovera$73
1 payment
  • Meals for Covera · 2020-01-23 · $73
Fresenius USA MarketingVelphoro$19
1 payment
  • Meals for Velphoro · 2020-02-11 · $19
AstraZeneca Pharmaceuticals LPLokelma$15
1 payment
  • Meals for Lokelma · 2020-02-04 · $15

2019: $1,682

Payments by company in 2019
AstraZeneca UKNone$1,336
8 payments
  • Meals · 2019-09-12 · $131
  • Meals · 2019-09-12 · $40
  • Meals · 2019-09-12 · $25
  • Meals · 2019-09-12 · $70
  • Travel · 2019-09-12 · $181
  • Travel · 2019-09-12 · $580
  • Travel · 2019-09-12 · $130
  • Travel · 2019-09-12 · $179
Baxter HealthcareRenal - Non Product Related$138
2 payments
  • Meals for Renal - Pd · 2019-10-08 · $14
  • Meals for Renal - Non Product Related · 2019-09-05 · $125
Alexion PharmaceuticalsNone$72
1 payment
  • Meals · 2019-04-15 · $72
Shire North American GroupGattex$47
2 payments
  • Meals for Gattex · 2019-08-01 · $25
  • Meals for Gattex · 2019-06-11 · $22
AmgenParsabiv$34
2 payments
  • Meals for Parsabiv · 2019-09-05 · $17
  • Meals for Parsabiv · 2019-09-05 · $17
Fresenius USA MarketingNone$20
1 payment
  • Meals · 2019-09-10 · $20
Otsuka America PharmaceuticalJynarque$18
1 payment
  • Meals for Jynarque · 2019-06-07 · $18
Mallinckrodt EnterprisesActhar$16
1 payment
  • Meals for Acthar · 2019-06-18 · $16

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
AstraZeneca Pharmaceuticals LP · A Phase 2b Multicenter Randomised Double Blind Placebo Controlled Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricemia · 2019Their institution$13,918
AstraZeneca Pharmaceuticals LP · A Phase 2b Multicenter Randomised Double Blind Placebo Controlled Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricemia · 2020Their institution$8,715
AstraZeneca Pharmaceuticals LP · A Phase 2b Multicenter Randomised Double Blind Placebo Controlled Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricemia · 2021Their institution$5,150
AstraZeneca Pharmaceuticals LP · A Phase 2b Multicenter Randomised Double Blind Placebo Controlled Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricemia · 2023Their institution$4,752

Professional record

NPI
1497752802
Licence
CT 041816
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CT 001418161
Taxonomy
Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2005-06-30
NPI last updated
2025-03-27
NPI record certified
2025-03-27

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 35 Jolley Dr, Bloomfield, CT, 06002